Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Querying RAS: How a Multiplex Assay Became a Robust Transcriptional Readout for HTS

In Q&A, scientists describe development and offer multiplexing tips

A few years ago, scientists at Merck & Co were looking for a better way to evaluate the activity of the RAS-MAPK pathway, which is particularly important for cancer development and can also signal susceptibility or resistance to emerging therapies. They used the Thermo Fisher QuantiGene™ Plex Gene Expression multiplex assay, based on xMAP® Technology, to develop a 26-gene signature to measure RAS activity.

Continue Reading >

Using Luminex to Help Treat Respiratory Patients



Dr. Gonzalez is a family practitioner who treats an eclectic mix of patients, young and old. He runs a smart practice and knows the value of syndromic testing as well as when a targeted approach makes better sense, especially when testing for a potential respiratory illness. Watch how he works to strategically treat two types of patients with respiratory infections.

Watch more videos >

Luminex on Twitter

In the midst of #MarchMadness, don't forget to up your game with Luminex platforms and multiplex assays. Our April…
h J R
Calculating commissions makes Irene happy, but the compensation analyst's dream job would actually be... a professi…
h J R
How did #multiplexing with #xMAP & the @thermofisher #QuantiGene assay enable @Merck to better investigate the…
h J R

Latest News

February 4
Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results

January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio

November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results

October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio

October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018


AACR Annual Meeting
March 31 – April 3
Atlanta, GA

APHL Newborn Screening & Genetic Testing Symposium
April 7-10
Chicago, IL

Immunology 2019
May 9-13
San Diego, CA